Patent · US Active

Crystal form of tri-cycle compound and application thereof

US11952388B2 · kind B2 · utility

0Cited by

2References

16Claims

0Family size

Assignee

FUJIAN AKEYLINK BIOTECHNOLOGY CO., LTD. · CN

Inventors

Jing Wang · Beijing, CN
Zhigan Jiang · Shanghai, CN
Haiying He · Shanghai, CN
Yaxun YANG · Shanghai, CN

Key dates

Filing date	Aug 23, 2019
Grant date	Apr 9, 2024
Priority date	—
Expiry date	Jul 29, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are crystal form A and crystal form B of a compound represented by formula (I), and application thereof in the preparation of medicaments for treating HBV-related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.